244 related articles for article (PubMed ID: 22889864)
1. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Maier PS; Spritzer PM
Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864
[TBL] [Abstract][Full Text] [Related]
2. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
3. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome.
Wiltgen D; Furtado L; Kohek MB; Spritzer PM
Gynecol Endocrinol; 2007 Mar; 23(3):173-8. PubMed ID: 17454172
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
[TBL] [Abstract][Full Text] [Related]
7. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
Uras R; Orrù M; Pani F; Marotto MF; Pilloni M; Guerriero S; Etzi R; Zedda P; Sorge R; Lello S; Melis GB; Paoletti AM
Contraception; 2010 Aug; 82(2):131-8. PubMed ID: 20654753
[TBL] [Abstract][Full Text] [Related]
8. The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Kaya MG; Calapkorur B; Karaca Z; Yildirim S; Celik A; Akpek M; Unluhizarci K; Kelestimur F
Clin Endocrinol (Oxf); 2012 Dec; 77(6):885-92. PubMed ID: 22563947
[TBL] [Abstract][Full Text] [Related]
9. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.
Ashraf S; Rasool SUA; Nabi M; Ganie MA; Masoodi SR; Amin S
Sci Rep; 2021 Jun; 11(1):12942. PubMed ID: 34155264
[TBL] [Abstract][Full Text] [Related]
10. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
[TBL] [Abstract][Full Text] [Related]
11. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
Carmina E; Azziz R
Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
[TBL] [Abstract][Full Text] [Related]
13. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study.
Cinar N; Harmanci A; Demir B; Yildiz BO
Hum Reprod; 2012 Jun; 27(6):1840-5. PubMed ID: 22473394
[TBL] [Abstract][Full Text] [Related]
14. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Ibáñez L; De Zegher F
Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
[TBL] [Abstract][Full Text] [Related]
15. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
Lecke SB; Morsch DM; Spritzer PM
Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
[TBL] [Abstract][Full Text] [Related]
17. Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome.
Mulders AG; ten Kate-Booij M; Pal R; De Kruif M; Nekrui L; Oostra BA; Fauser BC; Laven JS
Reprod Biomed Online; 2005 Dec; 11(6):690-6. PubMed ID: 16417732
[TBL] [Abstract][Full Text] [Related]
18. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
Xita N; Lazaros L; Georgiou I; Tsatsoulis A
Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]